• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment.中国山东省2型糖尿病患者对药物的偏好:一项离散选择实验
Patient Prefer Adherence. 2022 Aug 25;16:2335-2344. doi: 10.2147/PPA.S367985. eCollection 2022.
2
Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.评估中国 2 型糖尿病患者对口服抗糖尿病药物的偏好和支付意愿:一项离散选择实验。
Patient. 2024 Sep;17(5):565-574. doi: 10.1007/s40271-024-00694-7. Epub 2024 Apr 20.
3
Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.中国 2 型糖尿病患者的糖尿病治疗偏好:一项离散选择实验。
Front Public Health. 2022 Feb 1;9:782964. doi: 10.3389/fpubh.2021.782964. eCollection 2021.
4
Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.德国和西班牙2型糖尿病药物属性的患者偏好:一项在线离散选择实验调查。
Diabetes Ther. 2017 Dec;8(6):1365-1378. doi: 10.1007/s13300-017-0326-8. Epub 2017 Nov 3.
5
What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.2型糖尿病口服治疗中什么最重要?一项评估患者偏好的离散选择实验。
Eur J Health Econ. 2016 Dec;17(9):1125-1140. doi: 10.1007/s10198-015-0750-5. Epub 2015 Dec 18.
6
Preferences of patients with diabetes mellitus for primary healthcare institutions: a discrete choice experiment in China.糖尿病患者对基层医疗机构的偏好:中国的离散选择实验。
BMJ Open. 2023 Jun 27;13(6):e072495. doi: 10.1136/bmjopen-2023-072495.
7
Comparing the Self-Reported Acceptability of Discrete Choice Experiment and Best-Worst Scaling: An Empirical Study in Patients with Type 2 Diabetes Mellitus.比较离散选择实验和最佳-最差标度法的自我报告可接受性:2型糖尿病患者的实证研究
Patient Prefer Adherence. 2024 Aug 30;18:1803-1813. doi: 10.2147/PPA.S470310. eCollection 2024.
8
Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.英国 2 型糖尿病患者对药物属性的偏好。
Diabetes Obes Metab. 2013 Sep;15(9):802-9. doi: 10.1111/dom.12091. Epub 2013 Apr 7.
9
Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.个体化糖尿病管理:糖尿病患者更喜欢什么?一项离散选择实验。
Eur J Health Econ. 2021 Apr;22(3):425-443. doi: 10.1007/s10198-021-01264-6. Epub 2021 Feb 15.
10
Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment.通过离散选择实验理解糖尿病治疗属性的患者自付费用临界点。
J Manag Care Spec Pharm. 2023 Feb;29(2):139-150. doi: 10.18553/jmcp.2023.29.2.139.

引用本文的文献

1
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.
2
Preferences of patients with multiple chronic diseases for medication in rural areas of an Eastern Province China: a discrete choice experiment.中国东部某省农村地区慢性病患者的用药偏好:一项离散选择实验
Front Med (Lausanne). 2024 Oct 9;11:1439136. doi: 10.3389/fmed.2024.1439136. eCollection 2024.
3
Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.评估中国 2 型糖尿病患者对口服抗糖尿病药物的偏好和支付意愿:一项离散选择实验。
Patient. 2024 Sep;17(5):565-574. doi: 10.1007/s40271-024-00694-7. Epub 2024 Apr 20.

本文引用的文献

1
Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.中国 2 型糖尿病患者的糖尿病治疗偏好:一项离散选择实验。
Front Public Health. 2022 Feb 1;9:782964. doi: 10.3389/fpubh.2021.782964. eCollection 2021.
2
Prevalence and Treatment of Diabetes in China, 2013-2018.中国糖尿病患病率及治疗状况 2013-2018 年
JAMA. 2021 Dec 28;326(24):2498-2506. doi: 10.1001/jama.2021.22208.
3
Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.个体化糖尿病管理:糖尿病患者更喜欢什么?一项离散选择实验。
Eur J Health Econ. 2021 Apr;22(3):425-443. doi: 10.1007/s10198-021-01264-6. Epub 2021 Feb 15.
4
Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment.日本 2 型糖尿病患者对 GLP-1RA 治疗方案的口服和注射偏好:一项离散选择实验。
Adv Ther. 2021 Jan;38(1):721-738. doi: 10.1007/s12325-020-01561-1. Epub 2020 Nov 27.
5
How Do Type 2 Diabetes Patients Value Urban Integrated Primary Care in China? Results of a Discrete Choice Experiment.2 型糖尿病患者如何看待中国的城市综合初级保健?一项离散选择实验的结果。
Int J Environ Res Public Health. 2019 Dec 23;17(1):117. doi: 10.3390/ijerph17010117.
6
Illness perceptions among patients with type 2 diabetes mellitus: A cross-sectional study.2 型糖尿病患者的疾病感知:一项横断面研究。
Int J Nurs Pract. 2020 Oct;26(5):e12801. doi: 10.1111/ijn.12801. Epub 2019 Nov 27.
7
Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia.2017年伊朗南部2型糖尿病患者胰岛素治疗依从性的影响因素:我们面临胰岛素恐惧症。
Iran J Med Sci. 2019 May;44(3):204-213.
8
Discrete Choice Experiments in Health Economics: Past, Present and Future.健康经济学中的离散选择实验:过去、现在和未来。
Pharmacoeconomics. 2019 Feb;37(2):201-226. doi: 10.1007/s40273-018-0734-2.
9
Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article.2型糖尿病患者的低血糖:一篇综述文章。
Diabetes Metab Syndr. 2018 Sep;12(5):791-794. doi: 10.1016/j.dsx.2018.04.004. Epub 2018 Apr 12.
10
Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.遵循良好研究实践建议开展离散选择实验研究:一项用于引出患者对糖尿病治疗偏好的应用研究。
Value Health. 2018 Jan;21(1):59-68. doi: 10.1016/j.jval.2017.07.001. Epub 2017 Aug 7.

中国山东省2型糖尿病患者对药物的偏好:一项离散选择实验

Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment.

作者信息

Lv Yuyu, Ren Ru, Tang Chengxiang, Song Kuimeng, Li Shunping, Wang Haipeng

机构信息

Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

NHC Key Laboratory of Health Economics and Policy Research (Shandong University), Jinan, People's Republic of China.

出版信息

Patient Prefer Adherence. 2022 Aug 25;16:2335-2344. doi: 10.2147/PPA.S367985. eCollection 2022.

DOI:10.2147/PPA.S367985
PMID:36046499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9423121/
Abstract

PURPOSE

To evaluate preferences for medications among patients with type 2 diabetes mellitus (T2DM) from urban community health stations or rural village clinics in Shandong province, China.

METHODS

We use a discrete choice experiment (DCE) to measure the medication preferences. Each patient completed six DCE choice sets. The attributes for the DCE questionnaire include mode of administration, out-of-pocket medication cost per month, fasting blood glucose control effect and frequency of hypoglycemia events. The conditional logit model (Clogit) and mixed logit model (MXL) were used to evaluate choice data.

RESULTS

A total of 887 patients with T2DM completed the survey. The mean age of participants was 64 years, 36.42% experienced complications, and the mean duration of diabetes was about 8 years. Overall, patients' ideal medication would not have hypoglycemia events, provide normal fasting glucose levels, have oral medication three times a day and lower monthly medication cost. Patients prioritized the frequency of hypoglycemia events (β=15.055, P < 0.01) and were willing to spend CNY 393.10 per month to avoid hypoglycemia events. For patients with higher educational levels and with longer diagnosis time, the effect of fasting blood glucose was more relevant than all other outcomes.

CONCLUSION

This study provides information on T2DM patients' preference for medications. Our results suggest that clinical doctors should present patients with a variety of pharmaceutical characteristics and include their preference into medication decision, which will improve patient adherence and health outcomes.

摘要

目的

评估中国山东省城市社区卫生服务站或农村卫生室的2型糖尿病(T2DM)患者对药物的偏好。

方法

我们使用离散选择实验(DCE)来测量药物偏好。每位患者完成六个DCE选择集。DCE问卷的属性包括给药方式、每月自付药费、空腹血糖控制效果和低血糖事件发生频率。使用条件logit模型(Clogit)和混合logit模型(MXL)评估选择数据。

结果

共有887例T2DM患者完成调查。参与者的平均年龄为64岁,36.42%有并发症,糖尿病平均病程约8年。总体而言,患者理想的药物不会发生低血糖事件,能使空腹血糖水平正常,每日口服三次,且每月药费较低。患者将低血糖事件发生频率列为优先考虑因素(β=15.055,P<0.01),并且愿意每月花费393.10元来避免低血糖事件。对于教育程度较高和诊断时间较长的患者,空腹血糖的效果比所有其他结果更相关。

结论

本研究提供了T2DM患者对药物偏好的信息。我们的结果表明,临床医生应向患者介绍各种药物特性,并将患者的偏好纳入用药决策,这将提高患者的依从性和健康结局。